- LINKS
-
About us
Click here for more information about this topic.
Information for Download
Further information
More information
-
- (12)
- Printer friendly version
- Bookmark this page
- gross
Corporate profile
Bayer Schering Pharma is one of the ten largest specialty pharmaceutical companies in the world. We market our products in more than 100 countries, and in 2009 generated sales of almost € 10.5 billion.
-
Headquarters of Bayer Schering
Pharma AG
More than 36,000 members of staff currently work for Bayer Schering Pharma worldwide – more than 5,800 in research and development alone. We aim to improve people’s quality of life with our products. To achieve this, we concentrate on the research and development of innovative drugs and novel therapeutic approaches. At the same time, we are constantly improving established products. In this context, Bayer Schering Pharma uses experience it has gained from over a century in the business. We concentrate on four business units in which we make essential contributions to medical progress:
Facts and Figures
| Activities | > 100 countries worldwide |
| Sales in 2009 | approx. €10.5 billion |
| Employees | > 36,000, > 5,800 of them in research & development |
| Research areas | Oncology, Women’s Healthcare, Cardiology & Hematology, Diagnostic Imaging |
| Main research & development locations | Germany: Berlin, Wuppertal / Cologne / Leverkusen United States: Berkeley/California; Montville/New Jersey Japan: Osaka China: Beijing |
| Production locations | Europe, United States, Latin America and Asia |
| Research & development expenditure in 2009 | > €1.5 billion |
Main R&D fields
| Location | Main field |
|---|---|
| Berlin: | Diagnostic Imaging, Oncology and Women's Healthcare |
| Wuppertal: | Cardiology and Oncology |
| Berkeley: | Applied research and life cycle management in hemophilia and Multiple Sclerosis |
Information for Download



















